MedTech Dive - Latest News

Caris Life Sciences plans $424M IPO

Caris, which offers tools for disease diagnosis, therapy selection and treatment monitoring, is the latest company to test the medtech IPO market.

Jun 10, 2025 - 23:40
 0
Caris Life Sciences plans $424M IPO

Caris, which offers tools for disease diagnosis, therapy selection and treatment monitoring, is the latest company to test the medtech IPO market.

Read More

Tags:

Previous Article

The Wines, Chefs, and Stories That Defined the 2025 Nantucket Wine & Food Festival

Next Article

Metals little moved as trade talks continue

Related Posts

Freenome posts pivotal liquid biopsy data as FDA filing nears completion

Freenome posts pivotal liquid biopsy data as FDA filing...

Jun 4, 2025  0

HHS staffers sue over ‘hopelessly error-ridden’ layoffs

HHS staffers sue over ‘hopelessly error-ridden’ layoffs

Jun 5, 2025  0

FDA clears first blood test to aid Alzheimer’s diagnosis

FDA clears first blood test to aid Alzheimer’s diagnosis

May 19, 2025  0